Harvard awards basys.ai CEO Amber Nigam 2026 Alumni Innovation Award
Harvard awards basys.ai CEO Amber Nigam 2026 Alumni Innovation Award
PR Newswire
BOSTON, Aug. 7, 2026
BOSTON, Aug. 7, 2026 /PRNewswire/ -- Basys.ai today announced that its CEO and Co-founder, Amber Nigam, has received the 2026 Harvard Alumni Innovation Award from the Harvard T.H. Chan School of Public Health, the school's highest alumni recognition. The award is presented annually to a single alumnus whose work has made exceptional contributions to advancing public health through innovation in science, practice, education, or healthcare delivery.
Nigam was recognized for his leadership in applying artificial intelligence to address some of healthcare's most complex operational challenges. Through Basys.ai, he has helped advance explainable, domain-specific AI systems that support utilization management, prior authorization, payment integrity, fraud, waste, and abuse detection (FWA), and other high-impact healthcare workflows with transparency, reliability, and accountability.
"It is an incredible honor to receive this recognition from the Harvard T.H. Chan School of Public Health," said Amber Nigam, CEO and Co-founder of Basys.ai. "This award reflects the dedication of my team and our shared belief that AI should strengthen healthcare by making critical decisions more transparent, evidence-driven, and trustworthy. We're committed to building technology that improves how healthcare is delivered while keeping patients, clinicians, and healthcare organizations at the center of every decision."
The recognition builds on Basys.ai's continued momentum in advancing enterprise-grade, responsible AI across healthcare. The company's explainable AI platform supports healthcare organizations in interpreting clinical policies, analyzing medical records, and improving complex administrative workflows while maintaining transparency and human oversight. Basys.ai's work has also been recognized through national healthcare initiatives, academic research, and collaborations across the public and private sectors. The company was recently recognized in the CMS FWA White Paper for its approach to explainable, agentic AI and was named a national finalist in CMS's Crushing FWA Challenge.
Nigam has contributed to advancing responsible AI in healthcare through publications in Harvard Business Review, a TEDx talk on aligning incentives across the healthcare ecosystem, and presentations at leading academic and industry forums, including Harvard University, Stanford University, and the NCQA Health Innovation Summit, where he has shared perspectives on explainable AI and healthcare innovation. His leadership has also been recognized as one of Rock Health's Top 50 in Digital Health and as a Top Healthcare Technology CEO of 2025 by The Healthcare Technology Report.
About Basys.ai
Basys.ai is a healthcare AI company that has built proprietary, domain-specific, agentic AI systems for clinical and administrative workflows, including prior authorization, utilization management, payment integrity, FWA, and risk adjustment. The company supports healthcare organizations with transparent, auditable, and operationally reliable decision support.
Learn more: www.basys.ai
Media Contact:
communications@basys.ai
SOURCE basys.ai
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
6 ETFs To Diversify Away From AI
Why This Vanguard ETF Is One of the Best
The Best AI Stocks to Buy Now
United States